Bahamas vs Tonga: The number of people with susceptibility test result for rifampicin
Bahamas
12
in 2021
Tonga
7
in 2021
Bahamas rank
138th
Tonga rank
141st
The number of people with susceptibility test result for rifampicin over time
- Bahamas
- Tonga
How they compare
Bahamas currently reports 12 against 7 in Tonga, a difference of 5.
That makes Bahamas's figure about 1.7 times Tonga's.
Across all 5 years both countries report, Bahamas has been ahead every year.
Bahamas ranks 138th and Tonga ranks 141st of 155 countries.
Bahamas has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahamas | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.67 | 6 | 11.67 | Bahamas |
| 2020s | 16 | 6 | 10 | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahamas or Tonga?
- Bahamas, at 12 against 7 in Tonga as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahamas and Tonga?
- 5, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Tonga?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahamas and Tonga rank globally for the number of people with susceptibility test result for rifampicin?
- Bahamas ranks 138th and Tonga ranks 141st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.